Norges Bank
GTHX

Norges Bank’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Norges Bank’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-225,700
Closed -$1.23M – 2171
2022
Q4 		$1.23M Hold
225,700
– – ﹤0.01% 2031
2022
Q3 		$2.82M Buy
+225,700
New +$2.58M ﹤0.01% 1855
2018
Q2 		– Sell
-40,000
Closed -$1.48M – 2179
2018
Q1 		$1.48M Hold
40,000
– – ﹤0.01% 2033
2017
Q4 		$794K Hold
40,000
– – ﹤0.01% 2076
2017
Q3 		$996K Hold
40,000
– – ﹤0.01% 2062
2017
Q2 		$698K Buy
+40,000
New +$700K ﹤0.01% 2070

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank's GTHX Position: Q1 2023 in Review

Norges Bank sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2023, closing a stake of 225,700 shares — an estimated $1.23M sold.

Norges Bank first reported a position in GTHX in Q2 2017 and held it in 6 quarters. The position peaked at $2.82M in Q3 2022. 96 funds tracked by Wall St. Rank hold GTHX as of Q1 2023.

  • Norges Bank reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Norges Bank sold 225,700 G1 Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.23M.
  • Norges Bank first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 6 quarters.
  • Norges Bank's G1 Therapeutics, Inc. Common Stock position peaked at $2.82M in Q3 2022.
  • 96 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Norges Bank's 13F filing for Q1 2023, filed 15 May 2023.